The Efficacy and Safety of Avatrombopag for the Treatment of Children with Immune Thrombocytopenia (AVA-PED-301)

Authors
Category Primary study
Conference65th Annual Scientific Meeting of the British Society for Haematology
Year 2025
This article has no abstract
Epistemonikos ID: dc167ad4649db7e76b2780f65de35632dc8ea18f
First added on: Feb 21, 2026